CAPITAL GROUP INVESTMENT MANAGEMENT PTE. LTD.
Position in AMGN — Amgen Inc
CIK 1939970
Raffles Quay, U0
Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,473,104
-$620,755 QoQ
Shares Held
4,068
-31.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,444
of 3,140 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL GROUP INVESTMENT MANAGEMENT PTE. LTD. holds $46,759,706 across 7 Drug Manufacturers - General names. AMGN ranks #5 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
106,664 | $20,225,627 | |
| 2 | LLY |
ELI LILLY & Co
|
15,758 | $18,900,619 | |
| 3 | ABBV |
AbbVie Inc.
|
9,584 | $2,411,717 | |
| 4 | PFE |
Pfizer Inc
|
94,728 | $2,281,050 | |
| 5 | AMGN |
Amgen Inc
This page
|
4,068 | $1,473,104 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,400 | $887,348 | |
| 7 | GRFS |
Grifols SA
|
81,955 | $580,241 |
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,473,104 | 4,068 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,093,859 | 5,951 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,894,797 | 5,789 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,310,770 | 11,732 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,693,687 | 6,066 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,837,210 | 5,897 | Shares | Defined | 2025-05-12 | |
| 2024-03-31 | $1,385,207 | 4,872 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||